Piramal Pharma shares gained 5.25%, closing at ₹282.85 in the latest trading session. The company’s market capitalization increased to ₹37,498.79 crore, reflecting renewed investor confidence.
The stock experienced a traded volume of 120.70 lakh shares with a traded value of ₹334.57 crore. The 52-week range for the stock is ₹114.35 to ₹307.90, showcasing a significant rebound from its lows earlier this year.
This strong movement aligns with broader market sentiment favoring pharmaceutical companies, likely driven by optimistic sector outlooks and increased demand for healthcare solutions.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
